{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3601, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de075-d5a6-7501-a8bc-84db8e762dc3", "docSlug": "5b5a177477142e3b2cd38d3923cc88c7", "documentTitle": "Hipgnosis Songs Fund | Results Presentation Deck | 22 slides", "authorId": "hipgnosis-songs-fund", "authorName": "Hipgnosis Songs Fund", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "valuation_table", "function": "show_valuation_bridge", "notes": "Includes a scatter plot of vintage vs market multiple and a waterfall-style bridge for proceeds.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d5a6-7501-a8bc-84db8e762dc3/7", "deckHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3", "deckAnchorHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3#slide-7", "loopMatches": [ { "to": 9, "from": 7, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "f2837486-d113-4b3a-8599-92a4e88373a4", "evidence": "The deck presents the benefits of the proposed transaction, including the sale price in line with market comparables and the stronger continuing portfolio.", "position": 1, "objective": "To show the benefits of the proposed transaction", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.7, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 9, "from": 7, "beatId": "41ef9aa2-9e8c-4e1b-8e56-e1864c9e12ec", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The deck presents the proposed solution, including the sale to Hipgnosis Songs Capital and the benefits of the transaction.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d5a6-7501-a8bc-84db8e762dc3", "docSlug": "5b5a177477142e3b2cd38d3923cc88c7", "documentTitle": "Hipgnosis Songs Fund | Results Presentation Deck | 22 slides", "authorId": "hipgnosis-songs-fund", "authorName": "Hipgnosis Songs Fund", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses a comparison table to justify a portfolio disposal strategy by showing improved quality metrics in the remaining assets.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d5a6-7501-a8bc-84db8e762dc3/8", "deckHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3", "deckAnchorHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3#slide-8", "loopMatches": [ { "to": 9, "from": 7, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "f2837486-d113-4b3a-8599-92a4e88373a4", "evidence": "The deck presents the benefits of the proposed transaction, including the sale price in line with market comparables and the stronger continuing portfolio.", "position": 1, "objective": "To show the benefits of the proposed transaction", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.7, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 9, "from": 7, "beatId": "41ef9aa2-9e8c-4e1b-8e56-e1864c9e12ec", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The deck presents the proposed solution, including the sale to Hipgnosis Songs Capital and the benefits of the transaction.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d5a6-7501-a8bc-84db8e762dc3", "docSlug": "5b5a177477142e3b2cd38d3923cc88c7", "documentTitle": "Hipgnosis Songs Fund | Results Presentation Deck | 22 slides", "authorId": "hipgnosis-songs-fund", "authorName": "Hipgnosis Songs Fund", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d5a6-7501-a8bc-84db8e762dc3/9", "deckHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3", "deckAnchorHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3#slide-9", "loopMatches": [ { "to": 9, "from": 7, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "f2837486-d113-4b3a-8599-92a4e88373a4", "evidence": "The deck presents the benefits of the proposed transaction, including the sale price in line with market comparables and the stronger continuing portfolio.", "position": 1, "objective": "To show the benefits of the proposed transaction", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.7, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 9, "from": 7, "beatId": "41ef9aa2-9e8c-4e1b-8e56-e1864c9e12ec", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The deck presents the proposed solution, including the sale to Hipgnosis Songs Capital and the benefits of the transaction.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d5a6-7501-a8bc-84db8e762dc3", "docSlug": "5b5a177477142e3b2cd38d3923cc88c7", "documentTitle": "Hipgnosis Songs Fund | Results Presentation Deck | 22 slides", "authorId": "hipgnosis-songs-fund", "authorName": "Hipgnosis Songs Fund", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "key_messages", "function": "present_solution", "notes": "The slide outlines the strategic rationale and operational details of a 'Go-Shop' provision in a transaction.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d5a6-7501-a8bc-84db8e762dc3/10", "deckHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3", "deckAnchorHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3#slide-10", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d5a6-7501-a8bc-84db8e762dc3", "docSlug": "5b5a177477142e3b2cd38d3923cc88c7", "documentTitle": "Hipgnosis Songs Fund | Results Presentation Deck | 22 slides", "authorId": "hipgnosis-songs-fund", "authorName": "Hipgnosis Songs Fund", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "preempt_rebuttal", "function": "preempt_rebuttal", "notes": "Uses a stacked bar chart to visualize the 'out of the money' status of contingent bonus obligations relative to growth rates.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d5a6-7501-a8bc-84db8e762dc3/11", "deckHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3", "deckAnchorHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3#slide-11", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d5a6-7501-a8bc-84db8e762dc3", "docSlug": "5b5a177477142e3b2cd38d3923cc88c7", "documentTitle": "Hipgnosis Songs Fund | Results Presentation Deck | 22 slides", "authorId": "hipgnosis-songs-fund", "authorName": "Hipgnosis Songs Fund", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "valuation_table", "function": "show_valuation_bridge", "notes": "The chart illustrates the bridge from Gross Proceeds to Realised transaction proceeds, compared against the Fair Value.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d5a6-7501-a8bc-84db8e762dc3/12", "deckHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3", "deckAnchorHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3#slide-12", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d5a6-7501-a8bc-84db8e762dc3", "docSlug": "5b5a177477142e3b2cd38d3923cc88c7", "documentTitle": "Hipgnosis Songs Fund | Results Presentation Deck | 22 slides", "authorId": "hipgnosis-songs-fund", "authorName": "Hipgnosis Songs Fund", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "preempt_rebuttal", "function": "preempt_rebuttal", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d5a6-7501-a8bc-84db8e762dc3/13", "deckHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3", "deckAnchorHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3#slide-13", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d5a6-7501-a8bc-84db8e762dc3", "docSlug": "5b5a177477142e3b2cd38d3923cc88c7", "documentTitle": "Hipgnosis Songs Fund | Results Presentation Deck | 22 slides", "authorId": "hipgnosis-songs-fund", "authorName": "Hipgnosis Songs Fund", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "other", "function": "propose_solution", "notes": "The slide highlights a shift in fee structure, specifically introducing lower tiers for higher market capitalization levels.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d5a6-7501-a8bc-84db8e762dc3/14", "deckHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3", "deckAnchorHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3#slide-14", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d5a6-7501-a8bc-84db8e762dc3", "docSlug": "5b5a177477142e3b2cd38d3923cc88c7", "documentTitle": "Hipgnosis Songs Fund | Results Presentation Deck | 22 slides", "authorId": "hipgnosis-songs-fund", "authorName": "Hipgnosis Songs Fund", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "key_takeaways", "function": "summarize", "notes": "Slide 14 of the deck.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d5a6-7501-a8bc-84db8e762dc3/15", "deckHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3", "deckAnchorHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3#slide-15", "loopMatches": [ { "to": 16, "from": 15, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "3686f80a-6521-4a7f-90bb-53ebe42237a2", "evidence": "The deck presents a compelling case for the proposed transaction, highlighting the unique high-quality portfolio and the potential for higher growth.", "position": 2, "objective": "To provide a compelling case for the proposed transaction", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 16, "from": 15, "beatId": "93c653b1-2163-4823-8fd0-9f5de4f3b68c", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Desire", "beatSlug": "aida-desire", "evidence": "The deck creates desire for the proposed solution, highlighting the unique high-quality portfolio and the potential for higher growth.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d5a6-7501-a8bc-84db8e762dc3", "docSlug": "5b5a177477142e3b2cd38d3923cc88c7", "documentTitle": "Hipgnosis Songs Fund | Results Presentation Deck | 22 slides", "authorId": "hipgnosis-songs-fund", "authorName": "Hipgnosis Songs Fund", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "key_takeaways", "function": "summarize", "notes": "Includes a specific callout to Goldman Sachs forecasts as the source for growth data.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d5a6-7501-a8bc-84db8e762dc3/16", "deckHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3", "deckAnchorHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3#slide-16", "loopMatches": [ { "to": 16, "from": 15, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "3686f80a-6521-4a7f-90bb-53ebe42237a2", "evidence": "The deck presents a compelling case for the proposed transaction, highlighting the unique high-quality portfolio and the potential for higher growth.", "position": 2, "objective": "To provide a compelling case for the proposed transaction", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 16, "from": 15, "beatId": "93c653b1-2163-4823-8fd0-9f5de4f3b68c", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Desire", "beatSlug": "aida-desire", "evidence": "The deck creates desire for the proposed solution, highlighting the unique high-quality portfolio and the potential for higher growth.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d5a6-7501-a8bc-84db8e762dc3", "docSlug": "5b5a177477142e3b2cd38d3923cc88c7", "documentTitle": "Hipgnosis Songs Fund | Results Presentation Deck | 22 slides", "authorId": "hipgnosis-songs-fund", "authorName": "Hipgnosis Songs Fund", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "executive_summary", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d5a6-7501-a8bc-84db8e762dc3/17", "deckHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3", "deckAnchorHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3#slide-17", "loopMatches": [], "arcBeatMatches": [ { "to": 18, "from": 17, "beatId": "7c951016-11b4-48b0-9541-11618b7351fd", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck maintains interest, providing a summary of the key points and appendices.", "position": 4, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d5a6-7501-a8bc-84db8e762dc3", "docSlug": "5b5a177477142e3b2cd38d3923cc88c7", "documentTitle": "Hipgnosis Songs Fund | Results Presentation Deck | 22 slides", "authorId": "hipgnosis-songs-fund", "authorName": "Hipgnosis Songs Fund", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d5a6-7501-a8bc-84db8e762dc3/18", "deckHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3", "deckAnchorHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3#slide-18", "loopMatches": [], "arcBeatMatches": [ { "to": 18, "from": 17, "beatId": "7c951016-11b4-48b0-9541-11618b7351fd", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck maintains interest, providing a summary of the key points and appendices.", "position": 4, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d5a6-7501-a8bc-84db8e762dc3", "docSlug": "5b5a177477142e3b2cd38d3923cc88c7", "documentTitle": "Hipgnosis Songs Fund | Results Presentation Deck | 22 slides", "authorId": "hipgnosis-songs-fund", "authorName": "Hipgnosis Songs Fund", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "other", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d5a6-7501-a8bc-84db8e762dc3/19", "deckHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3", "deckAnchorHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d5a6-7501-a8bc-84db8e762dc3", "docSlug": "5b5a177477142e3b2cd38d3923cc88c7", "documentTitle": "Hipgnosis Songs Fund | Results Presentation Deck | 22 slides", "authorId": "hipgnosis-songs-fund", "authorName": "Hipgnosis Songs Fund", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "comparison_table", "function": "analyze_data", "notes": "The slide compares 'Pre First Disposal' vs 'Post First Disposal' metrics for Borrowing Policy and RCF LTV Covenant.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d5a6-7501-a8bc-84db8e762dc3/20", "deckHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3", "deckAnchorHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d5a6-7501-a8bc-84db8e762dc3", "docSlug": "5b5a177477142e3b2cd38d3923cc88c7", "documentTitle": "Hipgnosis Songs Fund | Results Presentation Deck | 22 slides", "authorId": "hipgnosis-songs-fund", "authorName": "Hipgnosis Songs Fund", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "appendix_disclosure", "function": "appendix", "notes": "The chart shows a positive correlation between two variables (likely catalogue size/revenue and valuation multiple).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d5a6-7501-a8bc-84db8e762dc3/21", "deckHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3", "deckAnchorHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d5a6-7501-a8bc-84db8e762dc3", "docSlug": "5b5a177477142e3b2cd38d3923cc88c7", "documentTitle": "Hipgnosis Songs Fund | Results Presentation Deck | 22 slides", "authorId": "hipgnosis-songs-fund", "authorName": "Hipgnosis Songs Fund", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "cover", "function": "front_matter", "notes": "Features the company logo.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d5a6-7501-a8bc-84db8e762dc3/22", "deckHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3", "deckAnchorHref": "/decks/019de075-d5a6-7501-a8bc-84db8e762dc3#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d647-710d-b5ca-0193642e1b4c", "docSlug": "2344f271f91233184d89da303e5a582f", "documentTitle": "Hyperfine | Investor Presentation Deck | 22 slides", "authorId": "hyperfine", "authorName": "Hyperfine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/3sOfheWcoJacNieFd79mjAo5xkymf4GiaWO7SShgLlk/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yMzQ0ZjI3MWY5MTIzMzE4NGQ4OWRhMzAzZTVhNTgyZi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d647-710d-b5ca-0193642e1b4c/1", "deckHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c", "deckAnchorHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/B2xT-009uwgV-VCMbaqD0jXbsf_OOid9nTqvXTTFCMI/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yMzQ0ZjI3MWY5MTIzMzE4NGQ4OWRhMzAzZTVhNTgyZi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/iCco0vo4qqj_IAKsFPs2lDixvz3nbd8lWgYKoUnUWsQ/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yMzQ0ZjI3MWY5MTIzMzE4NGQ4OWRhMzAzZTVhNTgyZi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/w4YtYrC9v5JOZjGXz3dHxJByVpqsFzqdfHnboGwDCkU/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yMzQ0ZjI3MWY5MTIzMzE4NGQ4OWRhMzAzZTVhNTgyZi9wMDAxLnBuZw" }, { "docId": "019de075-d647-710d-b5ca-0193642e1b4c", "docSlug": "2344f271f91233184d89da303e5a582f", "documentTitle": "Hyperfine | Investor Presentation Deck | 22 slides", "authorId": "hyperfine", "authorName": "Hyperfine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "appendix_disclosure", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d647-710d-b5ca-0193642e1b4c/2", "deckHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c", "deckAnchorHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d647-710d-b5ca-0193642e1b4c", "docSlug": "2344f271f91233184d89da303e5a582f", "documentTitle": "Hyperfine | Investor Presentation Deck | 22 slides", "authorId": "hyperfine", "authorName": "Hyperfine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "problem_statement", "function": "frame_problem", "notes": "This is a classic 'problem-solution' framing slide.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d647-710d-b5ca-0193642e1b4c/3", "deckHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c", "deckAnchorHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c#slide-3", "loopMatches": [ { "to": 3, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "7ec377e7-80ad-40ab-a883-3262ee86ace8", "evidence": "The problem statement on page 3 implies a cost of inaction loop.", "position": 1, "objective": "What are the consequences of not acting?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.5, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 3, "from": 3, "beatId": "a482c8de-c4d4-416b-b23f-a5b73d7778f0", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The problem statement is presented on page 3.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d647-710d-b5ca-0193642e1b4c", "docSlug": "2344f271f91233184d89da303e5a582f", "documentTitle": "Hyperfine | Investor Presentation Deck | 22 slides", "authorId": "hyperfine", "authorName": "Hyperfine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "solution", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d647-710d-b5ca-0193642e1b4c/4", "deckHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c", "deckAnchorHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 4, "beatId": "e44eea06-7e1f-4ed3-955e-237ec3d7bc29", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The solution is presented on pages 4-5.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d647-710d-b5ca-0193642e1b4c", "docSlug": "2344f271f91233184d89da303e5a582f", "documentTitle": "Hyperfine | Investor Presentation Deck | 22 slides", "authorId": "hyperfine", "authorName": "Hyperfine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "solution", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d647-710d-b5ca-0193642e1b4c/5", "deckHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c", "deckAnchorHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 4, "beatId": "e44eea06-7e1f-4ed3-955e-237ec3d7bc29", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The solution is presented on pages 4-5.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d647-710d-b5ca-0193642e1b4c", "docSlug": "2344f271f91233184d89da303e5a582f", "documentTitle": "Hyperfine | Investor Presentation Deck | 22 slides", "authorId": "hyperfine", "authorName": "Hyperfine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "mission", "function": "inspire_vision", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d647-710d-b5ca-0193642e1b4c/6", "deckHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c", "deckAnchorHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c#slide-6", "loopMatches": [ { "to": 6, "from": 6, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "b25c796c-8ccb-4c71-84d2-25e65c1120df", "evidence": "The mission statement on page 6 implies a golden circle loop.", "position": 0, "objective": "Why is this important?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d647-710d-b5ca-0193642e1b4c", "docSlug": "2344f271f91233184d89da303e5a582f", "documentTitle": "Hyperfine | Investor Presentation Deck | 22 slides", "authorId": "hyperfine", "authorName": "Hyperfine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "comparison_table", "function": "compare_peers", "notes": "The table uses a traffic light system (green, yellow, red) to visually indicate performance across categories.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d647-710d-b5ca-0193642e1b4c/7", "deckHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c", "deckAnchorHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 8, "from": 7, "beatId": "f8275cf3-ce8e-470e-9883-54de1c7f7fff", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "The market size and comparison tables are presented on pages 7-8.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d647-710d-b5ca-0193642e1b4c", "docSlug": "2344f271f91233184d89da303e5a582f", "documentTitle": "Hyperfine | Investor Presentation Deck | 22 slides", "authorId": "hyperfine", "authorName": "Hyperfine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses a comparison framework to contrast traditional vs. new product workflows.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d647-710d-b5ca-0193642e1b4c/8", "deckHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c", "deckAnchorHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 8, "from": 7, "beatId": "f8275cf3-ce8e-470e-9883-54de1c7f7fff", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "The market size and comparison tables are presented on pages 7-8.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d647-710d-b5ca-0193642e1b4c", "docSlug": "2344f271f91233184d89da303e5a582f", "documentTitle": "Hyperfine | Investor Presentation Deck | 22 slides", "authorId": "hyperfine", "authorName": "Hyperfine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a before-after framing to contrast traditional centralized MRI with the decentralized Swoop system.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d647-710d-b5ca-0193642e1b4c/9", "deckHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c", "deckAnchorHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c#slide-9", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d647-710d-b5ca-0193642e1b4c", "docSlug": "2344f271f91233184d89da303e5a582f", "documentTitle": "Hyperfine | Investor Presentation Deck | 22 slides", "authorId": "hyperfine", "authorName": "Hyperfine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "roadmap", "function": "plan_implementation", "notes": "Uses a process flow diagram to illustrate the evolution from current commercial use to future expansion.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d647-710d-b5ca-0193642e1b4c/10", "deckHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c", "deckAnchorHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c#slide-10", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d647-710d-b5ca-0193642e1b4c", "docSlug": "2344f271f91233184d89da303e5a582f", "documentTitle": "Hyperfine | Investor Presentation Deck | 22 slides", "authorId": "hyperfine", "authorName": "Hyperfine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d647-710d-b5ca-0193642e1b4c/11", "deckHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c", "deckAnchorHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c#slide-11", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d647-710d-b5ca-0193642e1b4c", "docSlug": "2344f271f91233184d89da303e5a582f", "documentTitle": "Hyperfine | Investor Presentation Deck | 22 slides", "authorId": "hyperfine", "authorName": "Hyperfine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a list of specific study examples to build credibility.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d647-710d-b5ca-0193642e1b4c/12", "deckHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c", "deckAnchorHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 18, "from": 12, "beatId": "75ac9b1a-2d2a-4255-aa40-a596075f8995", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Traction is presented on pages 12-18, including clinical proof, regulatory excellence, and financial strength.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d647-710d-b5ca-0193642e1b4c", "docSlug": "2344f271f91233184d89da303e5a582f", "documentTitle": "Hyperfine | Investor Presentation Deck | 22 slides", "authorId": "hyperfine", "authorName": "Hyperfine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "traction", "function": "show_traction", "notes": "The slide highlights regulatory milestones as a proxy for product validation and market readiness.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d647-710d-b5ca-0193642e1b4c/13", "deckHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c", "deckAnchorHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 18, "from": 12, "beatId": "75ac9b1a-2d2a-4255-aa40-a596075f8995", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Traction is presented on pages 12-18, including clinical proof, regulatory excellence, and financial strength.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d647-710d-b5ca-0193642e1b4c", "docSlug": "2344f271f91233184d89da303e5a582f", "documentTitle": "Hyperfine | Investor Presentation Deck | 22 slides", "authorId": "hyperfine", "authorName": "Hyperfine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "solution", "function": "present_solution", "notes": "The central icon represents the Hyperfine device, surrounded by five support pillars.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d647-710d-b5ca-0193642e1b4c/14", "deckHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c", "deckAnchorHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 18, "from": 12, "beatId": "75ac9b1a-2d2a-4255-aa40-a596075f8995", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Traction is presented on pages 12-18, including clinical proof, regulatory excellence, and financial strength.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d647-710d-b5ca-0193642e1b4c", "docSlug": "2344f271f91233184d89da303e5a582f", "documentTitle": "Hyperfine | Investor Presentation Deck | 22 slides", "authorId": "hyperfine", "authorName": "Hyperfine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "roadmap", "function": "show_traction", "notes": "The slide uses a diagonal timeline layout to represent product evolution.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d647-710d-b5ca-0193642e1b4c/15", "deckHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c", "deckAnchorHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 18, "from": 12, "beatId": "75ac9b1a-2d2a-4255-aa40-a596075f8995", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Traction is presented on pages 12-18, including clinical proof, regulatory excellence, and financial strength.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d647-710d-b5ca-0193642e1b4c", "docSlug": "2344f271f91233184d89da303e5a582f", "documentTitle": "Hyperfine | Investor Presentation Deck | 22 slides", "authorId": "hyperfine", "authorName": "Hyperfine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "traction", "function": "show_traction", "notes": "The 2023 figure is marked with an asterisk indicating revenue guidance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d647-710d-b5ca-0193642e1b4c/16", "deckHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c", "deckAnchorHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c#slide-16", "loopMatches": [], "arcBeatMatches": [ { "to": 18, "from": 12, "beatId": "75ac9b1a-2d2a-4255-aa40-a596075f8995", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Traction is presented on pages 12-18, including clinical proof, regulatory excellence, and financial strength.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d647-710d-b5ca-0193642e1b4c", "docSlug": "2344f271f91233184d89da303e5a582f", "documentTitle": "Hyperfine | Investor Presentation Deck | 22 slides", "authorId": "hyperfine", "authorName": "Hyperfine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "traction", "function": "show_traction", "notes": "The chart shows a progression from negative margin to positive margin.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d647-710d-b5ca-0193642e1b4c/17", "deckHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c", "deckAnchorHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c#slide-17", "loopMatches": [], "arcBeatMatches": [ { "to": 18, "from": 12, "beatId": "75ac9b1a-2d2a-4255-aa40-a596075f8995", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Traction is presented on pages 12-18, including clinical proof, regulatory excellence, and financial strength.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d647-710d-b5ca-0193642e1b4c", "docSlug": "2344f271f91233184d89da303e5a582f", "documentTitle": "Hyperfine | Investor Presentation Deck | 22 slides", "authorId": "hyperfine", "authorName": "Hyperfine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a bar chart to demonstrate financial discipline and outlines three key areas of investment.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d647-710d-b5ca-0193642e1b4c/18", "deckHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c", "deckAnchorHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c#slide-18", "loopMatches": [], "arcBeatMatches": [ { "to": 18, "from": 12, "beatId": "75ac9b1a-2d2a-4255-aa40-a596075f8995", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Traction is presented on pages 12-18, including clinical proof, regulatory excellence, and financial strength.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d647-710d-b5ca-0193642e1b4c", "docSlug": "2344f271f91233184d89da303e5a582f", "documentTitle": "Hyperfine | Investor Presentation Deck | 22 slides", "authorId": "hyperfine", "authorName": "Hyperfine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "team_bio", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d647-710d-b5ca-0193642e1b4c/19", "deckHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c", "deckAnchorHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c#slide-19", "loopMatches": [], "arcBeatMatches": [ { "to": 19, "from": 19, "beatId": "9c7922b1-6808-4aee-8663-141b21fc2f94", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Team", "beatSlug": "sequoia-pitch-team", "evidence": "The leadership team is presented on page 19.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d647-710d-b5ca-0193642e1b4c", "docSlug": "2344f271f91233184d89da303e5a582f", "documentTitle": "Hyperfine | Investor Presentation Deck | 22 slides", "authorId": "hyperfine", "authorName": "Hyperfine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "executive_summary", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d647-710d-b5ca-0193642e1b4c/20", "deckHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c", "deckAnchorHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d647-710d-b5ca-0193642e1b4c", "docSlug": "2344f271f91233184d89da303e5a582f", "documentTitle": "Hyperfine | Investor Presentation Deck | 22 slides", "authorId": "hyperfine", "authorName": "Hyperfine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d647-710d-b5ca-0193642e1b4c/21", "deckHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c", "deckAnchorHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d647-710d-b5ca-0193642e1b4c", "docSlug": "2344f271f91233184d89da303e5a582f", "documentTitle": "Hyperfine | Investor Presentation Deck | 22 slides", "authorId": "hyperfine", "authorName": "Hyperfine", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "appendix_disclosure", "function": "cite_precedent", "notes": "The slide serves as a bibliography of peer-reviewed research supporting the company's portable MRI technology.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d647-710d-b5ca-0193642e1b4c/22", "deckHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c", "deckAnchorHref": "/decks/019de075-d647-710d-b5ca-0193642e1b4c#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d6ea-7495-b63c-e64074d45b72", "docSlug": "3f99bbe59467be363a98d21e99cb078a", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/CstfTIV4uxy1j3KktI0BFfr4jnw9NCFPvXhDggj0s70/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zZjk5YmJlNTk0NjdiZTM2M2E5OGQyMWU5OWNiMDc4YS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/1", "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72", "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "fdd7f9e1-2682-4247-94a2-fdce5088590c", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Attention", "beatSlug": "aida-attention", "evidence": "The deck starts with a cover slide, disclaimer, and executive summary", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/u2aI1WBtGXJJiM2fRK5VrE5-0SD_S0CHIT6v71hk7CA/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zZjk5YmJlNTk0NjdiZTM2M2E5OGQyMWU5OWNiMDc4YS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/FRTs6cZHP0BVdXyO9ahn0ZsF-XLa8kOWhPaZQJrZ2so/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zZjk5YmJlNTk0NjdiZTM2M2E5OGQyMWU5OWNiMDc4YS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/8C6cWvU2Xp_lnQ-0esxmRGK6biNWytFR4DboFRUvv_s/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zZjk5YmJlNTk0NjdiZTM2M2E5OGQyMWU5OWNiMDc4YS9wMDAxLnBuZw" }, { "docId": "019de075-d6ea-7495-b63c-e64074d45b72", "docSlug": "3f99bbe59467be363a98d21e99cb078a", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/2", "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72", "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "fdd7f9e1-2682-4247-94a2-fdce5088590c", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Attention", "beatSlug": "aida-attention", "evidence": "The deck starts with a cover slide, disclaimer, and executive summary", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d6ea-7495-b63c-e64074d45b72", "docSlug": "3f99bbe59467be363a98d21e99cb078a", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a numbered list format to present key value propositions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/3", "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72", "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "fdd7f9e1-2682-4247-94a2-fdce5088590c", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Attention", "beatSlug": "aida-attention", "evidence": "The deck starts with a cover slide, disclaimer, and executive summary", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d6ea-7495-b63c-e64074d45b72", "docSlug": "3f99bbe59467be363a98d21e99cb078a", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "pain_points", "function": "frame_problem", "notes": "The slide uses a hub-and-spoke diagram to illustrate the central problem of CAR-T neurotoxicity and its four primary negative outcomes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/4", "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72", "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 27, "from": 4, "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck presents the problem, solution, competitive analysis, and traction", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d6ea-7495-b63c-e64074d45b72", "docSlug": "3f99bbe59467be363a98d21e99cb078a", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "solution", "function": "present_solution", "notes": "Includes a cartoon mascot at the bottom.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/5", "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72", "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 27, "from": 4, "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck presents the problem, solution, competitive analysis, and traction", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d6ea-7495-b63c-e64074d45b72", "docSlug": "3f99bbe59467be363a98d21e99cb078a", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a visual comparison to highlight the safety advantage of NXC-201, specifically focusing on neurotoxicity and CRS duration.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/6", "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72", "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 27, "from": 4, "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck presents the problem, solution, competitive analysis, and traction", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d6ea-7495-b63c-e64074d45b72", "docSlug": "3f99bbe59467be363a98d21e99cb078a", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "market_sizing", "function": "size_opportunity", "notes": "Uses a visual icon-grid to represent market expansion from 5% of hospitals to a much broader network.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/7", "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72", "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 27, "from": 4, "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck presents the problem, solution, competitive analysis, and traction", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d6ea-7495-b63c-e64074d45b72", "docSlug": "3f99bbe59467be363a98d21e99cb078a", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "unfair_advantage", "function": "present_solution", "notes": "The slide uses a molecular biology diagram to illustrate the structural difference in the binding domain of the NXC-201 therapy compared to competitors.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/8", "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72", "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 27, "from": 4, "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck presents the problem, solution, competitive analysis, and traction", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d6ea-7495-b63c-e64074d45b72", "docSlug": "3f99bbe59467be363a98d21e99cb078a", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "product_demo", "function": "present_solution", "notes": "Includes comparative bar charts and flow cytometry data.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/9", "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72", "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-9", "loopMatches": [ { "to": 10, "from": 9, "name": "Aha Moment", "slug": "03-aha-moment", "bestFor": "Data-heavy sections, research findings, analytical arguments", "matchId": "8d02a94e-79b8-4ba4-920c-87f81d998140", "evidence": "The deck presents NXC-201's MoA and clinical highlights", "position": 0, "objective": "Understanding NXC-201's mechanism of action", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "confidence": 0.7, "description": "Establish a tension, present data, then deliver the insight that changes everything" } ], "arcBeatMatches": [ { "to": 27, "from": 4, "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck presents the problem, solution, competitive analysis, and traction", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d6ea-7495-b63c-e64074d45b72", "docSlug": "3f99bbe59467be363a98d21e99cb078a", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a comparative timeline/chart layout to contrast clinical outcomes of three different therapies.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/10", "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72", "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-10", "loopMatches": [ { "to": 10, "from": 9, "name": "Aha Moment", "slug": "03-aha-moment", "bestFor": "Data-heavy sections, research findings, analytical arguments", "matchId": "8d02a94e-79b8-4ba4-920c-87f81d998140", "evidence": "The deck presents NXC-201's MoA and clinical highlights", "position": 0, "objective": "Understanding NXC-201's mechanism of action", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "confidence": 0.7, "description": "Establish a tension, present data, then deliver the insight that changes everything" } ], "arcBeatMatches": [ { "to": 27, "from": 4, "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck presents the problem, solution, competitive analysis, and traction", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d6ea-7495-b63c-e64074d45b72", "docSlug": "3f99bbe59467be363a98d21e99cb078a", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "traction", "function": "show_traction", "notes": "The chart demonstrates the efficacy of NXC-201 (formerly HBI0101) in clearing diseased cells.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/11", "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72", "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 27, "from": 4, "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck presents the problem, solution, competitive analysis, and traction", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d6ea-7495-b63c-e64074d45b72", "docSlug": "3f99bbe59467be363a98d21e99cb078a", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a process flow diagram to connect cellular pathology to clinical symptoms in the heart, liver, and kidneys.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/12", "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72", "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 27, "from": 4, "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck presents the problem, solution, competitive analysis, and traction", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d6ea-7495-b63c-e64074d45b72", "docSlug": "3f99bbe59467be363a98d21e99cb078a", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "Includes extensive source citations in the footer.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/13", "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72", "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 27, "from": 4, "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck presents the problem, solution, competitive analysis, and traction", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d6ea-7495-b63c-e64074d45b72", "docSlug": "3f99bbe59467be363a98d21e99cb078a", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses a table structure to contrast treatment outcomes and patient growth across three stages of multiple myeloma.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/14", "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72", "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 27, "from": 4, "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck presents the problem, solution, competitive analysis, and traction", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d6ea-7495-b63c-e64074d45b72", "docSlug": "3f99bbe59467be363a98d21e99cb078a", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a visual comparison to highlight a 67% improvement in response rates for NXC-201 compared to competitors.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/15", "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72", "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 27, "from": 4, "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck presents the problem, solution, competitive analysis, and traction", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d6ea-7495-b63c-e64074d45b72", "docSlug": "3f99bbe59467be363a98d21e99cb078a", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "roadmap", "function": "plan_implementation", "notes": "Includes FDA approval precedents in the footer to establish credibility.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/16", "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72", "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-16", "loopMatches": [], "arcBeatMatches": [ { "to": 27, "from": 4, "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck presents the problem, solution, competitive analysis, and traction", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d6ea-7495-b63c-e64074d45b72", "docSlug": "3f99bbe59467be363a98d21e99cb078a", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "traction", "function": "show_traction", "notes": "Includes detailed clinical trial citations in the footer.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/17", "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72", "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-17", "loopMatches": [], "arcBeatMatches": [ { "to": 27, "from": 4, "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck presents the problem, solution, competitive analysis, and traction", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d6ea-7495-b63c-e64074d45b72", "docSlug": "3f99bbe59467be363a98d21e99cb078a", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a two-column layout to separate milestones by drug candidate.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/18", "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72", "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-18", "loopMatches": [], "arcBeatMatches": [ { "to": 27, "from": 4, "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck presents the problem, solution, competitive analysis, and traction", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d6ea-7495-b63c-e64074d45b72", "docSlug": "3f99bbe59467be363a98d21e99cb078a", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a side-by-side comparison structure to explain two distinct but complementary technology platforms.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/19", "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72", "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-19", "loopMatches": [], "arcBeatMatches": [ { "to": 27, "from": 4, "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck presents the problem, solution, competitive analysis, and traction", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d6ea-7495-b63c-e64074d45b72", "docSlug": "3f99bbe59467be363a98d21e99cb078a", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "roadmap", "function": "show_traction", "notes": "The table uses a standard pharmaceutical pipeline format, categorizing by clinical vs preclinical status and highlighting specific regulatory and clinical trial milestones.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/20", "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72", "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-20", "loopMatches": [], "arcBeatMatches": [ { "to": 27, "from": 4, "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck presents the problem, solution, competitive analysis, and traction", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d6ea-7495-b63c-e64074d45b72", "docSlug": "3f99bbe59467be363a98d21e99cb078a", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "why_now", "function": "argue_timing", "notes": "Combines market sizing data with a 'Why Now' narrative supported by industry news clippings and a comparative efficacy table.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/21", "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72", "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-21", "loopMatches": [ { "to": 22, "from": 21, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "0ad98d72-f65a-494f-a999-cb32332eed00", "evidence": "The deck explains NXC-201's market opportunity and potential", "position": 1, "objective": "Understanding why NXC-201 is entering large markets", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 27, "from": 4, "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck presents the problem, solution, competitive analysis, and traction", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-d6ea-7495-b63c-e64074d45b72", "docSlug": "3f99bbe59467be363a98d21e99cb078a", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 58 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide uses a wave-like visual to represent market segments and their associated valuations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-d6ea-7495-b63c-e64074d45b72/22", "deckHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72", "deckAnchorHref": "/decks/019de075-d6ea-7495-b63c-e64074d45b72#slide-22", "loopMatches": [ { "to": 22, "from": 21, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "0ad98d72-f65a-494f-a999-cb32332eed00", "evidence": "The deck explains NXC-201's market opportunity and potential", "position": 1, "objective": "Understanding why NXC-201 is entering large markets", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 27, "from": 4, "beatId": "e890a8f4-ce5b-494a-9258-fdd0f87cc84b", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Interest", "beatSlug": "aida-interest", "evidence": "The deck presents the problem, solution, competitive analysis, and traction", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }